Branched-chain amino acid supplementation in treatment of liver cirrhosis: Updated views on how to attenuate their harmful effects on cataplerosis and ammonia formation.

[1]  G. Marchesini,et al.  Branched-chain amino acids for people with hepatic encephalopathy. , 2017, The Cochrane database of systematic reviews.

[2]  Y. Nishida,et al.  Effects of home‐based exercise and branched‐chain amino acid supplementation on aerobic capacity and glycemic control in patients with cirrhosis , 2017, Hepatology research : the official journal of the Japan Society of Hepatology.

[3]  D. V. Van Wagoner,et al.  Hyperammonaemia‐induced skeletal muscle mitochondrial dysfunction results in cataplerosis and oxidative stress , 2016, The Journal of physiology.

[4]  M. Holeček,et al.  Phenylbutyrate exerts adverse effects on liver regeneration and amino acid concentrations in partially hepatectomized rats , 2016, International journal of experimental pathology.

[5]  M. Holeček,et al.  Alterations in protein and amino acid metabolism in rats fed a branched-chain amino acid- or leucine-enriched diet during postprandial and postabsorptive states , 2016, Nutrition & Metabolism.

[6]  N. Deutz,et al.  Metabolic and molecular responses to leucine‐enriched branched chain amino acid supplementation in the skeletal muscle of alcoholic cirrhosis , 2015, Hepatology.

[7]  M. Holeček.  Ammonia and amino acid profiles in liver cirrhosis: effects of variables leading to hepatic encephalopathy. , 2015, Nutrition.

[8]  R. Shephard,et al.  Effects of physical activity upon the liver , 2014, European Journal of Applied Physiology.

[9]  C. Van Noorden,et al.  Determination of Glutamate Dehydrogenase Activity and Its Kinetics in Mouse Tissues using Metabolic Mapping (Quantitative Enzyme Histochemistry) , 2014, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[10]  E. Román,et al.  Randomized Pilot Study: Effects of an Exercise Programme and Leucine Supplementation in Patients with Cirrhosis , 2014, Digestive Diseases and Sciences.

[11]  J. A. Arranz,et al.  Safety of Ornithine Phenylacetate in Cirrhotic Decompensated Patients: An Open-label, Dose-escalating, Single-cohort Study , 2013, Journal of clinical gastroenterology.

[12]  M. Holeček.  Branched-chain amino acids and ammonia metabolism in liver disease: therapeutic implications. , 2013, Nutrition.

[13]  M. Holeček.  Evidence of a vicious cycle in glutamine synthesis and breakdown in pathogenesis of hepatic encephalopathy–therapeutic perspectives , 2013, Metabolic Brain Disease.

[14]  Jiansheng Huang,et al.  Characterization of the regulation and function of zinc‐dependent histone deacetylases during rodent liver regeneration , 2013, Hepatology.

[15]  A. Schousboe,et al.  Interorgan metabolism of ornithine phenylacetate (OP)--a novel strategy for treatment of hyperammonemia. , 2013, Biochemical pharmacology.

[16]  M. Rogero,et al.  Effects of Diets Supplemented with Branched-Chain Amino Acids on the Performance and Fatigue Mechanisms of Rats Submitted to Prolonged Physical Exercise , 2012, Nutrients.

[17]  Hong Bu,et al.  Impairment of liver regeneration by the histone deacetylase inhibitor valproic acid in mice , 2012, Journal of Zhejiang University SCIENCE B.

[18]  Y. Hiasa,et al.  Aerobic exercise improves insulin resistance and decreases body fat and serum levels of leptin in patients with hepatitis C virus , 2011, Hepatology research : the official journal of the Japan Society of Hepatology.

[19]  A. Schousboe,et al.  Branched-chain amino acids increase arterial blood ammonia in spite of enhanced intrinsic muscle ammonia metabolism in patients with cirrhosis and healthy subjects. , 2011, American journal of physiology. Gastrointestinal and liver physiology.

[20]  N. Brunetti‐Pierri,et al.  Phenylbutyrate therapy for maple syrup urine disease. , 2011, Human molecular genetics.

[21]  M. Kovarik,et al.  Acute hyperammonemia activates branched-chain amino acid catabolism and decreases their extracellular concentrations: different sensitivity of red and white muscle , 2011, Amino Acids.

[22]  M. Holeček.  Three targets of branched-chain amino acid supplementation in the treatment of liver disease. , 2010, Nutrition.

[23]  M. Ferraz,et al.  A critical analysis of studies assessing L-ornithine-L-aspartate (LOLA) in hepatic encephalopathy treatment. , 2009, Arquivos de gastroenterologia.

[24]  M. Malaguarnera,et al.  Branched chain amino acids supplemented with L-acetylcarnitine versus BCAA treatment in hepatic coma: a randomized and controlled double blind study , 2009, European journal of gastroenterology & hepatology.

[25]  K. Eguchi,et al.  A snack enriched with oral branched-chain amino acids prevents a fall in albumin in patients with liver cirrhosis undergoing chemoembolization for hepatocellular carcinoma. , 2009, Nutrition research.

[26]  A. Ono,et al.  Evaluation of the effects of combination therapy with branched‐chain amino acid and zinc supplements on nitrogen metabolism in liver cirrhosis , 2007, Hepatology research : the official journal of the Japan Society of Hepatology.

[27]  Y. Nakaya,et al.  BCAA-enriched snack improves nutritional state of cirrhosis. , 2007, Nutrition.

[28]  Jessica E. Bolden,et al.  Anticancer activities of histone deacetylase inhibitors , 2006, Nature Reviews Drug Discovery.

[29]  M. Regan,et al.  Branched-Chain Amino Acids: Metabolism, Physiological Function, and Application Branched-Chain Amino Acid Requirements in Healthy Adult Human Subjects , 2005 .

[30]  M. Norenberg,et al.  Mechanisms of Ammonia-Induced Astrocyte Swelling , 2005, Metabolic Brain Disease.

[31]  M. Holeček,et al.  Plasma amino acid levels after carbon tetrachloride induced acute liver damage. A dose-response and time-response study in rats , 2005, Amino Acids.

[32]  S. Shirreffs,et al.  The effect of acute branched-chain amino acid supplementation on prolonged exercise capacity in a warm environment , 2004, European Journal of Applied Physiology.

[33]  M. Romero-Gómez,et al.  Intestinal glutaminase activity is increased in liver cirrhosis and correlates with minimal hepatic encephalopathy. , 2004, Journal of hepatology.

[34]  D. Legemate,et al.  Effects of a Branched-Chain Amino Acid-Enriched Diet on Chronic Hepatic Encephalopathy in Dogs , 1999, Metabolic Brain Disease.

[35]  R. Gatti,et al.  Branched-chainα-amino acid chronic treatment: responses of plasmaα-keto-related compounds and ammonia when used in physical exercise performance , 1996, Amino Acids.

[36]  M. Holeček,et al.  Plasma amino acids in four models of experimental liver injury in rats , 1996, Amino Acids.

[37]  G. Palaiologos,et al.  Effects of branched chain amino acids, pyruvate, or ketone bodies on the free amino acid pool and release from brain cortex slices of normal and streptozotocindiabetic rats , 2004, Neurochemical Research.

[38]  M. Rennie,et al.  Changes in blood ammonia, lactate and amino acids in relation to workload during bicycle ergometer exercise in man , 2004, European Journal of Applied Physiology and Occupational Physiology.

[39]  H. Moriwaki,et al.  Nocturnal branched-chain amino acid administration improves protein metabolism in patients with liver cirrhosis: comparison with daytime administration. , 2003, JPEN. Journal of parenteral and enteral nutrition.

[40]  M. Holeček,et al.  The BCAA-BCKA cycle: its relation to alanine and glutamine synthesis and protein balance. , 2001, Nutrition.

[41]  M. Holeček,et al.  Metabolism of branched-chain amino acids in starved rats: the role of hepatic tissue. , 2001, Physiological research.

[42]  M. Holeček,et al.  Effect of hyperammonemia on leucine and protein metabolism in rats. , 2000, Metabolism: clinical and experimental.

[43]  J. Davis,et al.  Serotonin and central nervous system fatigue: nutritional considerations. , 2000, The American journal of clinical nutrition.

[44]  M. Hargreaves,et al.  Effect of short-term training on mitochondrial ATP production rate in human skeletal muscle. , 1999, Journal of applied physiology.

[45]  M. Yudkoff,et al.  Brain metabolism of branched‐chain amino acids , 1997, Glia.

[46]  G. Kircheis,et al.  Therapeutic efficacy of L‐ornithine‐L‐aspartate infusions in patients with cirrhosis and hepatic encephalopathy: Results of a placebo‐controlled, double‐blind study , 1997, Hepatology.

[47]  B. Kiens,et al.  Effects of glucose, glucose plus branched-chain amino acids, or placebo on bike performance over 100 km. , 1996, Journal of applied physiology.

[48]  R. Breitkreutz,et al.  Hyperammonemia-induced depletion of glutamate and branched-chain amino acids in muscle and plasma. , 1996, Journal of hepatology.

[49]  B. Saltin,et al.  Stimulation of muscle ammonia production during exercise following branched‐chain amino acid supplementation in humans. , 1996, The Journal of physiology.

[50]  M. Holeček.  Leucine metabolism in fasted and tumor necrosis factor-treated rats. , 1996, Clinical nutrition.

[51]  M. Holeček,et al.  Leucine metabolism in rats with cirrhosis. , 1996, Journal of hepatology.

[52]  G. J. van der Vusse,et al.  Deamination of amino acids as a source for ammonia production in human skeletal muscle during prolonged exercise. , 1995, The Journal of physiology.

[53]  N. Omori,et al.  Administration of a branched-chain amino acid preparation during hepatic failure: a study emphasizing ammonia metabolism. , 1994, Acta medica Okayama.

[54]  M. Rennie,et al.  Sodium‐dependent glutamate transport in cultured rat myotubes increases after glutamine deprivation , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[55]  C. Kortsik,et al.  Effects of ornithine aspartate on plasma ammonia and plasma amino acids in patients with cirrhosis. A double-blind, randomized study using a four-fold crossover design. , 1993, Journal of hepatology.

[56]  L. Gluud,et al.  Branched-chain amino acids for hepatic encephalopathy. , 2003, The Cochrane database of systematic reviews.

[57]  L. Cynober.  Ornithine alpha-ketoglutarate in nutritional support. , 1991, Nutrition.

[58]  S. Brusilow.  Phenylacetylglutamine May Replace Urea as a Vehicle for Waste Nitrogen Excretion , 1991, Pediatric Research.

[59]  J. Knapik,et al.  Leucine metabolism during fasting and exercise. , 1991, Journal of applied physiology.

[60]  G. Marchesini,et al.  Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy: A randomized double-blind casein-controlled trial☆ , 1990 .

[61]  S. Kelsen,et al.  Effects of branched‐chain amino acids on nitrogen metabolism in patients with cirrhosis , 1990, Hepatology.

[62]  W. Souba,et al.  Dietary modulation of small intestinal glutamine transport in intestinal brush border membrane vesicles of rats. , 1990, The Journal of surgical research.

[63]  A. Wagenmakers,et al.  Metabolism of Branched-Chain Amino Acids and Ammonia During Exercise: Clues from McArdle's Disease* , 1990, International journal of sports medicine.

[64]  M. Buse,et al.  Administration of endotoxin, tumor necrosis factor, or interleukin 1 to rats activates skeletal muscle branched-chain alpha-keto acid dehydrogenase. , 1990, The Journal of clinical investigation.

[65]  A. Watanabe,et al.  Ammonia detoxification by accelerated oxidation of branched chain amino acids in brains of acute hepatic failure rats. , 1986, Biochemical medicine and metabolic biology.

[66]  J. Fischer,et al.  Infusion of branched-chain amino acids and ammonium salts in rats with portacaval shunts. , 1985, Archives of surgery.

[67]  E. Schiff,et al.  Comparison of Dietary Protein with an Oral, Branched Chain‐Enriched Amino Acid Supplement in Chronic Portal‐Systemic Encephalopathy: A Randomized Controlled Trial , 1984, Hepatology.

[68]  R. Miller,et al.  Branched-chain amino acid metabolism. , 1984, Annual review of nutrition.

[69]  M. Okita,et al.  Effect of a branched chain amino acid-enriched nutritional product on the pathophysiology of the liver and nutritional state of patients with liver cirrhosis. , 1983, Acta medica Okayama.

[70]  R. Baldessarini,et al.  False neurotransmitters and hepatic failure. , 1971, Lancet.

[71]  S. Brusilow,et al.  Plasma α-Ketoglutarate in Urea Cycle Enzymopathies and Its Role as a Harbinger of Hyperammonemic Coma , 1980, Pediatric Research.

[72]  J. Felber,et al.  Effects of ornithine alphaketoglutarate on blood insulin, glucagon and aminoacids in alcoholic cirrhosis. , 1979, Biomedicine / [publiee pour l'A.A.I.C.I.G.].

[73]  P. Bacon,et al.  D-PENICILLAMINE-INDUCED NEPHROPATHY , 1975, The Lancet.